Literature DB >> 14659518

Factor analysis validates the cluster structure of the dendrogram underlying the Multidimensional Affect and Pain Survey (MAPS) and challenges the a priori classification of the descriptors in the McGill Pain Questionnaire (MPQ).

Crawford W Clark1, John P Kuhl, Mary Louise Keohan, Helena Knotkova, Rachel T Winer, Germaine A Griswold.   

Abstract

The purpose of this study was to validate the content and structure of the Multidimensional Affect and Pain Survey (MAPS) by means of factor analysis. The 101-MAPS is based on a dendrogram obtained by cluster analysis and contains 30 clusters subsumed within three superclusters. If the MAPS is a valid questionnaire for the quantification of emotion and pain in patients, then factor analysis of patients' intensity ratings should produce factors which correspond to the cluster structure of the dendrogram. To confirm the structure of the dendrogram and hence, MAPS, factor analysis was applied to the responses by 100 outpatients diagnosed with early stage cancer. Principal components analysis of responses to the MAPS yielded six factors. In accordance with the hypothesis, 13 of the 17 clusters within the MAPS somatosensory pain supercluster loaded on three sensory factors: factor 1, severe sensory pain; factor 3, moderate sensory pain; and factor 6, numb/cold. Five of the eight clusters within the emotional pain supercluster loaded on factor 2, negative emotions. Four of the five clusters in the well-being supercluster loaded on factor 4, good health. Factor 5, manageable illness was loaded on by clusters from the well-being supercluster and the somatosensory pain supercluster. The homogeneity of the six factors found demonstrate the validity of the MAPS and the cluster structure of the dendrogram. MAPS proved sensitive to sex differences; women endorsed the negative emotions factor more strongly than did men. The MAPS factors were much more homogeneous than those reported in the literature for the McGill Pain Questionnaire.

Entities:  

Mesh:

Year:  2003        PMID: 14659518     DOI: 10.1016/j.pain.2003.08.005

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  7 in total

1.  Sex differences and hormonal influences on response to mechanical pressure pain in humans.

Authors:  William J Kowalczyk; Maria A Sullivan; Suzette M Evans; Adam M Bisaga; Suzanne K Vosburg; Sandra D Comer
Journal:  J Pain       Date:  2009-10-22       Impact factor: 5.820

2.  Validation of the care notebook for measuring physical, mental and life well-being of patients with cancer.

Authors:  Kunihiko Kobayashi; Joseph Green; Mari Shimonagayoshi; Noriaki Kanemoto; Ryo Kasai; Yoichi Itoh; Yuki Fujiki; Yasuo Ohashi; Carolyn Gotay; Shoji Kudoh
Journal:  Qual Life Res       Date:  2005-05       Impact factor: 4.147

3.  Exploratory and confirmatory factor analysis of the PROMIS pain quality item bank.

Authors:  Dennis A Revicki; Karon F Cook; Dagmar Amtmann; Neesha Harnam; Wen-Hung Chen; Francis J Keefe
Journal:  Qual Life Res       Date:  2013-07-09       Impact factor: 4.147

4.  Feeling too hot or cold after breast cancer: is it just a nuisance or a potentially important prognostic factor?

Authors:  Kathleen M Kokolus; Chi-Chen Hong; Elizabeth A Repasky
Journal:  Int J Hyperthermia       Date:  2010       Impact factor: 3.914

5.  The effects of exergaming on pain, postural control, technology acceptance and flow experience in older people with chronic musculoskeletal pain: a randomised controlled trial.

Authors:  Jae-Llane Ditchburn; Paul van Schaik; John Dixon; Alasdair MacSween; Denis Martin
Journal:  BMC Sports Sci Med Rehabil       Date:  2020-10-09

6.  Exploratory factor analysis of the pain outcomes profile.

Authors:  Gary J Sipps; Leon C Howard
Journal:  J Clin Psychol Med Settings       Date:  2013-03

Review 7.  Emerging Clinical Technology: Application of Machine Learning to Chronic Pain Assessments Based on Emotional Body Maps.

Authors:  Pavel Goldstein; Yoni Ashar; Jonas Tesarz; Mehmet Kazgan; Burak Cetin; Tor D Wager
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 7.620

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.